Skip to main content
Journal cover image

The role of hyaluronan degradation products as innate alloimmune agonists.

Publication ,  Journal Article
Tesar, BM; Jiang, D; Liang, J; Palmer, SM; Noble, PW; Goldstein, DR
Published in: Am J Transplant
November 2006

Dendritic cells (DCs) play a key role in initiating alloimmunity yet the substances that activate them during the host response to transplantation remain elusive. In this study we examined the potential roles of endogenous innate immune agonists in activating dendritic cell-dependent alloimmunity. Using a murine in vitro culture system, we show that 135 KDa fragments of the extracellular matrix glycosaminoglycan hyaluronan induce dendritic cell maturation and initiate alloimmunity. Priming of alloimmunity by hyaluronan-activated DCs was dependent on signaling via TIR-associated protein, a Toll-like receptor (TLR) adaptor downstream of TLRs 2 and 4. However, this effect was independent of alternate TLR adaptors, MyD88 or Trif. Using an in vivo murine transplant model, we show that hyaluronan accumulated during skin transplant rejection. Examination of human lung transplant recipients demonstrated that increased levels of intragraft hyaluronan were associated with bronchiolitis obliterans syndrome. In conclusion, our study suggests that fragments of hyaluronan can act as innate immune agonists that activate alloimmunity.

Duke Scholars

Published In

Am J Transplant

DOI

ISSN

1600-6135

Publication Date

November 2006

Volume

6

Issue

11

Start / End Page

2622 / 2635

Location

United States

Related Subject Headings

  • Tumor Necrosis Factor-alpha
  • Toll-Like Receptor 8
  • Toll-Like Receptor 4
  • Surgery
  • Skin Transplantation
  • Oligosaccharides
  • Myeloid Differentiation Factor 88
  • Mice, Knockout
  • Mice, Inbred C57BL
  • Mice
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tesar, B. M., Jiang, D., Liang, J., Palmer, S. M., Noble, P. W., & Goldstein, D. R. (2006). The role of hyaluronan degradation products as innate alloimmune agonists. Am J Transplant, 6(11), 2622–2635. https://doi.org/10.1111/j.1600-6143.2006.01537.x
Tesar, B. M., D. Jiang, J. Liang, S. M. Palmer, P. W. Noble, and D. R. Goldstein. “The role of hyaluronan degradation products as innate alloimmune agonists.Am J Transplant 6, no. 11 (November 2006): 2622–35. https://doi.org/10.1111/j.1600-6143.2006.01537.x.
Tesar BM, Jiang D, Liang J, Palmer SM, Noble PW, Goldstein DR. The role of hyaluronan degradation products as innate alloimmune agonists. Am J Transplant. 2006 Nov;6(11):2622–35.
Tesar, B. M., et al. “The role of hyaluronan degradation products as innate alloimmune agonists.Am J Transplant, vol. 6, no. 11, Nov. 2006, pp. 2622–35. Pubmed, doi:10.1111/j.1600-6143.2006.01537.x.
Tesar BM, Jiang D, Liang J, Palmer SM, Noble PW, Goldstein DR. The role of hyaluronan degradation products as innate alloimmune agonists. Am J Transplant. 2006 Nov;6(11):2622–2635.
Journal cover image

Published In

Am J Transplant

DOI

ISSN

1600-6135

Publication Date

November 2006

Volume

6

Issue

11

Start / End Page

2622 / 2635

Location

United States

Related Subject Headings

  • Tumor Necrosis Factor-alpha
  • Toll-Like Receptor 8
  • Toll-Like Receptor 4
  • Surgery
  • Skin Transplantation
  • Oligosaccharides
  • Myeloid Differentiation Factor 88
  • Mice, Knockout
  • Mice, Inbred C57BL
  • Mice